2017
DOI: 10.4081/dr.2017.7050
|View full text |Cite
|
Sign up to set email alerts
|

Actinic prurigo in Scandinavian adolescent successfully treated with cyclosporine A

Abstract: Actinic prurigo is a pruritic sun-induced dermatosis classified among the immunologically mediated photodermatoses. The disease is a well-known entity among Native Americans and in Central and South America, however rare in Caucasians with only a few reports from Australia, Britain and France. We report the first case of actinic prurigo in a Scandinavian patient, responding favorably to systemic treatment with cyclosporine A.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
3
0

Year Published

2019
2019
2024
2024

Publication Types

Select...
3
1

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(3 citation statements)
references
References 7 publications
(10 reference statements)
0
3
0
Order By: Relevance
“…Although rare in Caucasians with only a few instances from Australia, Britain and France, the disease is well-known among Native Americans and in Central and South America. [ 54 ]…”
Section: Discussionmentioning
confidence: 99%
“…Although rare in Caucasians with only a few instances from Australia, Britain and France, the disease is well-known among Native Americans and in Central and South America. [ 54 ]…”
Section: Discussionmentioning
confidence: 99%
“…Photoprotective strategies, topical corticosteroids, and antihistamines rarely achieve adequate symptomatic control. Thalidomide and cyclosporine can be effective, but side effects limit their use 2,3 …”
Section: Discussionmentioning
confidence: 99%
“…Thalidomide and cyclosporine can be effective, but side effects limit their use. 2,3 Actinic prurigo is a type IV hypersensitivity reaction, but the exact mechanistic pathway is unknown. Ultraviolet light liberates TNF-α from keratinocytes triggering the Th1 cell-mediated inflammatory pathway resulting in apoptosis, which forms the rationale for thalidomide therapy.…”
Section: A S Ementioning
confidence: 99%